X

Trial Profile

A first Phase 3 Pivotal study of mdHACM injection in the treatment of Knee Osteoarthritis

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 06 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DHACM (Primary)
Indications Osteoarthritis
Focus Registrational; Therapeutic Use
Sponsors MiMedx

Most Recent Events

28 Feb 2023 Status changed from planning to recruiting, according to an MiMedx media release.
15 Jun 2022 According to a MiMedx media release, MIMEDX engages Nordic Bioscience Clinical Development A/S to propel registrational trials of placental biologic injectable for Knee Osteoarthritis
15 Jun 2022 According to a MiMedx media release, the company expects to initiate this trial later this year.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com